Dow Corning and claimants reject settlement change
This article was originally published in Clinica
Both sides in the Dow Corning breast implant settlement have asked a federal district court judge in the US to overrule a recent judgement that would allow women with silicone breast implants who reject the settlement plan offered by Dow Corning to sue the parent companies Dow Chemical or Corning.
You may also be interested in...
The European public assessment report for Kaftrio shows that EU regulators had concerns about whether Vertex’s triple drug combination for cystic fibrosis represented a new treatment paradigm.
Swissmedic says its good manufacturing practice certificates remain valid for longer than companies might assume. Separately, it is giving companies more time to conduct nitrosamine-related risk evaluations.
Stada has appointed a head of digital communications; PGEU elects new chair and vice-chair; and the new UK health claims committee unveils its first members.